Large-scale reorganization begins March 18, 2019
FDA announces several new initiatives affecting medical device manufacturers.
Ending tax breaks to oil and gas companies would replace the lost tax revenue.
They know it’s a problem, just not a high priority.
The systematic study of “X-radiation” was an important milestone on the path to developing valuable medical diagnostics and therapies.
A reminder to stay on top of how pending healthcare rules and regulations may impact your customers.
Pharma is all in, and medical device companies need to jump on board to investigate ways to leverage this new application of biotechnology.
Artificial intelligence is here, and it's here to stay.
Not legally enforceable, but stakeholders should still address cyber vulnerabilities.
Supply chain automation can yield benefits in unexpected areas.